Immunovant IMVT Earnings Call Transcripts

NASDAQ IMVT
$35.71 +0.56 (+1.59%)
At close: Nov 10, 2026 · 4:00 PM EST
2 earnings calls on file for Immunovant, from Q2 2025 to Q1 2027. Each transcript opens in a new tab.
Latest earnings call

Immunovant Q1 2027 Earnings Call

Aug 6, 2026 9,126 words · 40 min read
  • Matthew GlineChief Executive Officer
  • Stephanie Lee GriffinInvestor Relations
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Immunovant Earnings Call Transcripts

Calls2
LatestAug 6, 2026
SinceQ2 2025

Fiscal 2027

Fiscal 2025

All 2 Immunovant transcripts Register to get access to Immunovant’s earnings call transcripts.